申请人:Janssen Vaccines & Prevention B.V.
公开号:US10738083B2
公开(公告)日:2020-08-11
The present invention relates to novel peptidomimetic compounds that are capable of binding to and/or neutralizing influenza viruses, in particular influenza A viruses of phylogenetic group 1, and to pharmaceutical compositions comprising such compounds. The invention also relates to the use of the peptidomimetic compounds in the diagnosis, prophylaxis and/or treatment of influenza virus infections.
本发明涉及能够结合和/或中和流感病毒(尤其是系统发育群1的甲型流感病毒)的新型拟肽化合物,以及包含此类化合物的药物组合物。本发明还涉及拟肽化合物在诊断、预防和/或治疗流感病毒感染中的用途。